ClinicalTrials.gg
RecruitingNCT04196712ECAD registryUpdated Dec 24, 2024

Essen Coronary Artery Disease Registry

An observational study in Coronary Artery Disease, sponsored by University Hospital, Essen. Recruiting at 1 site in Germany. Per ClinicalTrials.gov, last updated 2024-12-24.

Sponsored by University Hospital, Essen · Observational

How we know

From the registry’s dates

  • Started Sep 2019; still recruiting 7 years 2 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
55,000
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 365 studies in Coronary Artery Disease with a site in Germany — 46 open to participants now, 71 under way, 3 of them phase 3. Coronary Artery Disease · Germany.

Planned enrollment
4th of 117
55,000 · median 550
Started
2019
with 12 others
Observational
117 of 365
22 open now
Primary completion
2026-12
later than 34 of 70 live
Registered
289th of 365
by date

Among the 365 studies in Coronary Artery Disease with a site in Germany, this one is the 4th largest by planned enrollment of the 117 observational ones that give a count, is one of 13 that started in 2019, is one of 117 observational ones, reaches primary completion later than 34 of the 70 other live ones, and was the 289th registered.

Coronary Artery Disease

4,866 studies on the registry are indexed under Coronary Artery Disease; 892 are open to participants now.

Browse Coronary Artery Disease studies →

Open to participants now

46 of the 365 studies in Coronary Artery Disease with a site in Germany are open now. Recruiting first, the newest first:

41 more — sign in →

All 46 open studies →

A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →

Who these studies take

Of the 591 Coronary Artery Disease studies recruiting now, 404 (68%) set no upper age limit and 68 (12%) stop at 75 or younger; 37 take children under 18; 49 take healthy volunteers.

This study: all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 365 studies in Coronary Artery Disease with a site in Germany, or all of them as a file.
02

Study summary

The ECAD registry is a registry of patients undergoing coronary angiography at the West German Heart and Vascular Center. The registry anticipates to determine predictors of patient outcome after coronary angiography.

03

Conditions studied

  • Coronary Artery Disease
04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

This registry includes all consecutive patients undergoing invasive coronary angiography at the West German Heart and Vascular Center, starting from 2003.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients undergoing invasive coronary angiography at the West German Heart and Vascular Center

Exclusion criteria

Exclusion Criteria:

  • None
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
55,000 participants (estimated)
Target follow-up
3 Years
Patient registry
Yes

Groups and cohorts

  • Coronary angiography arm

    Patient undergoing invasive coronary angiography

06

What researchers measure

Primary outcomes

  1. All-cause mortality

    Mortality of any cause

    Time frame: through study completion, an average of 3 year

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Sep 2019 (actual). Primary completion is estimated for Dec 2026, 87 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 5, 2019
First posted
Dec 12, 2019
StartActual
Sep 1, 2019
Primary completionEst.
Dec 30, 2026
CompletionEst.
Jun 30, 2027
Last update
Dec 24, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 24, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04196712
Responsible party
Sponsor
First posted
Dec 12, 2019
Start date
Sep 1, 2019
Primary completion
Dec 30, 2026 (estimated)
Completion
Jun 30, 2027 (estimated)
Last update
Dec 24, 2024

Study contacts

Amir A Mahabadi, MD
Contact
amir-abbas.mahabadi@uk-essen.de
+49 201 723 ext. 84822
Matthias Totzeck, MD
Contact
matthias.totzeck@uk-essen.de
+49 201 723 ext. 84805
Tienush Rassaf, MD
principal investigator · University Hospital Essen, Deparment of Cardiology and Vascular Medicine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion